4Kapsi SG,Ayres JW. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability[J]. Int J Pharm,2001,229(3):193- 203
2Montillo M, Mirto S, Petti MC, et al. Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia [J]. American Journal of Hematology, 1998,58(2):105-109.
3Lee WL, Yuan CC, Chao HT, et al. Vaginal obliteration after total body irradiation and chemotherapy as treatment for acute myeloid leukemia [J]. European Journal of Obstetrics, Gynecology & Reproductive Biology, 2000,90(1):77-79.
4Mattiuzzi GN, Estey E, Raad I, et al. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infaetions during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome[J].Cancer, 2003,97(2):450-456.
5Auner HW, Sill H, Mulabecirovic A, et al.Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma[J]. Annals of Hematology, 2002,81(7):374-377.
